Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03277339Phase 4Completed
Phase 4, randomised, open-label trial (2 arms), sponsored by Centre Hospitalier Henri Laborit. Primary endpoint: Decrease Insula activity during a resting state task at Day 24. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03277339.